Jazz Pharmaceuticals PLC

23 oct. 2026, 23:56 UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, rebounding sharply after an initial decline, reflecting a cumulative gain since Friday's close.

22 oct. 2026, 20:13 UTC

Jazz Pharmaceuticals PLC shares advanced in after-market trading, reflecting a notable uptick since Thursday's close while remaining below its 20-day moving average.

21 oct. 2026, 19:26 UTC

Morgan Stanley analyst Jeffrey Hung lowered the price target on Jazz Pharmaceuticals to $314.00 from $322.00 while maintaining an Overweight rating.

20 oct. 2026, 20:08 UTC

Jazz Pharmaceuticals PLC shares advanced, reaching a peak early in the session before pulling back slightly, while trading below its 20-day moving average.

19 oct. 2026, 19:16 UTC

Jazz Pharmaceuticals PLC shares are declining sharply, currently trading significantly below their 20-day moving average and near the lower end of their one-month range.

16 oct. 2026, 21:01 UTC

Jazz Pharmaceuticals PLC declined in after-market trading, continuing a trend of unusual weakness since Friday's close and remaining below its 20-day moving average.

15 oct. 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares are advancing, continuing a positive trend since Wednesday's close, despite earlier pulling back from a session high.

14 oct. 2026, 19:36 UTC

Jazz Pharmaceuticals PLC shares are advancing, having pulled back from an earlier peak, while remaining below their 20-day moving average.

13 oct. 2026, 20:02 UTC

Jazz Pharmaceuticals PLC shares fell lower, marking a departure from recent higher daily closes amid shifts in broader market momentum.

12 oct. 2026, 19:16 UTC

Jazz Pharmaceuticals PLC shares fell modestly, continuing a trend of three consecutive sessions with lower closes, despite a brief recovery earlier in the day.

9 oct. 2026, 23:45 UTC

Jazz Pharmaceuticals PLC shares are trading slightly lower in after-market hours, marking three consecutive daily declines and remaining significantly below their 20-day moving average.

8 oct. 2026, 20:02 UTC

RBC Capital analyst Leonid Timashev lowered Jazz Pharmaceuticals' price target to $296.00 from $299.00 while keeping an Outperform rating.

7 oct. 2026, 21:21 UTC

In after-market trading, Jazz Pharmaceuticals PLC saw a notable increase, reaching a peak return after gaining higher since Wednesday's close.

6 oct. 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares declined after Director Bruce C. Cozadd sold 6k shares, with the stock remaining significantly below its 20-day moving average.

1 oct. 2026, 19:25 UTC

Jazz Pharmaceuticals PLC is trading higher, reflecting positive movement since Wednesday's close, despite retracing from an earlier peak and remaining below its 20-day moving average.

30 sept. 2026, 20:07 UTC

Jazz Pharmaceuticals PLC shares fell as the broader market showed weakness, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

29 sept. 2026, 20:02 UTC

Jazz Pharmaceuticals PLC shares fell sharply, reaching their lowest cumulative return since Monday and trading well below the 20-day moving average.

28 sept. 2026, 20:51 UTC

Jazz Pharmaceuticals PLC rose significantly in after-market trading, advancing notably since Monday's close, despite earlier fluctuations into negative territory.

25 sept. 2026, 19:15 UTC

Jazz Pharmaceuticals PLC is trading modestly higher, having peaked at nearly 1% earlier, though it remains below its 20-day moving average.

24 sept. 2026, 21:03 UTC

Jazz Pharmaceuticals PLC is trading modestly lower in after-market hours, struggling to maintain gains and dipping below its 20-day moving average.

23 sept. 2026, 20:02 UTC

Jazz Pharmaceuticals PLC shares fell sharply, reaching an early high before declining significantly, currently below the 20-day moving average and near a one-month low.

22 sept. 2026, 19:16 UTC

Jazz Pharmaceuticals PLC shares fell modestly, currently trading below their 20-day moving average and near the lower end of their one-month range.

21 sept. 2026, 20:51 UTC

Jazz Pharmaceuticals PLC's stock has declined in after-market trading, remaining significantly below its 20-day moving average and near the bottom of its one-month trading range.

18 sept. 2026, 20:06 UTC

Jazz Pharmaceuticals PLC shares fell sharply, reaching a session low amid broader market performance challenges and remaining below its 20-day moving average.

17 sept. 2026, 20:13 UTC

Jazz Pharmaceuticals PLC saw a modest decline during after-market hours on Thursday, remaining below its 20-day moving average amid broader market weakness.

15 sept. 2026, 20:02 UTC

Jazz Pharmaceuticals PLC's acquisition of Actio Biosciences for $820 million enhances its epilepsy pipeline, but shares are lower today following an earlier peak.

11 sept. 2026, 20:02 UTC

UBS raised its price target on Jazz Pharmaceuticals to $337, maintaining a Buy rating amid confidence in growth prospects. Shares are trading higher today.

8 sept. 2026, 20:03 UTC

Jazz Pharmaceuticals PLC is declining amid broader pharmaceuticals sector weakness, breaking a recent trend of higher daily closes since Friday.

4 sept. 2026, 19:36 UTC

Jazz Pharmaceuticals PLC shares are lower today amid rising Treasury yields and strong labor market data, reflecting broader market trends.

3 sept. 2026, 21:21 UTC

Jazz Pharmaceuticals PLC shares are lower in after-market hours, reflecting ongoing pressure despite broader market strength and decreasing rate hike expectations.